When Does the Cardiovascular Disease Appear in Patients With Chronic Kidney Disease?

被引:10
|
作者
Sozeri, Betul [1 ]
Mir, Sevgi [1 ]
Kara, Orhan Deniz [1 ]
Levent, Erturk [2 ]
机构
[1] Ege Univ, Fac Med, Dept Pediat Nephrol, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Pediat Cardiol, Izmir, Turkey
关键词
Cardiovascular disease; Children; Chronic kidney disease; LEFT-VENTRICULAR MASS; STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; ARTERIAL STIFFNESS; PEDIATRIC-PATIENTS; AORTIC STIFFNESS; ABDOMINAL-AORTA; YOUNG-ADULTS; CHILDREN; RISK;
D O I
10.1007/s00246-010-9710-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is a leading cause of long-term morbidity and mortality among children with chronic kidney disease (CKD). At which stage of CKD these appear in children is unknown. This study aimed to determine the prevalence of cardiovascular disease in pediatric CKD patients and to explore the relationship of these changes and treatment methods. The study enrolled pediatric patients with stages 1-5 CKD including 20 patients receiving predialysis (PreD), 8 receiving peritoneal dialysis, and 14 receiving hemodialysis. Aortic stiffness, defined as decreased aortic strain (S) and increased pressure strain normalized by diastolic pressure (Ep*), was described. Sonography of the common carotid artery and left ventricle was performed. The mean age of the children was 13.3 +/- A 5.3 years. The patients had lower S values (0.35 +/- A 0.23) than the control subjects (0.44 +/- A 0.2) (P < 0.05) but higher Ep* (2.46 +/- A 1.31 vs. 1.32 +/- A 0.09; P < 0.05). Aortic stiffness was found in 13 patients. The PreD group had lower As levels than the dialysis group but higher levels than the control group. The patients (n = 32) had greater carotid intima-media thickness than the control subjects (0.58 +/- A 0.14 vs. 0.35 +/- A 0.12; P < 0.05). The intima-media thickness was greatest in the PreD group (P < 0.05). The patients had a higher left ventricular mass index (LVMI; 42.4 +/- A 15.6) than the control subjects (28.8 +/- A 8.47) (P < 0.05) and a larger left ventricle end diastolic diameter (LVEDD; 3.44 +/- A 0.76 vs. 2.59 +/- A 0.34; P < 0.05). Left ventricular hypertrophy was found in 32 patients. Both LVMI and LVEDD were higher in the groups receiving hemodialysis and lower in the PreD group. Increased carotid-intima media thickness and left ventricle hypertrophy appeared without hypertension in the PreD group. The indications and timing of dialysis should be reevaluated for children with CKD. In the dialysis groups, fewer cardiovascular changes were found with peritoneal dialysis than with hemodialysis. Therefore, peritoneal dialysis should be preferable to hemodialysis for children with CKD.
引用
收藏
页码:821 / 828
页数:8
相关论文
共 50 条
  • [41] Depression and incident cardiovascular disease among patients with chronic kidney disease
    D'Oro, Anthony
    Patel, Devansh Himanshu
    Wass, Sojin
    Dolber, Trygve
    Nasir, Khurram
    Dobre, Mirela
    Rahman, Mahboob
    Al-Kindi, Sadeer
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 18
  • [42] Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease
    Kendrick, Jessica
    Chonchol, Michel B.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (12): : 672 - 681
  • [43] Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease
    Goicoechea, MA
    NEFROLOGIA, 2004, 24 (06): : 142 - 160
  • [44] Prevalence of Chronic Kidney Disease in Patients With or at a High Risk of Cardiovascular Disease
    Cases Amenos, Aleix
    Gonzalez-Juanatey, Jose R.
    Conthe Gutierrez, Pedro
    Matali Gilarranz, Arantxa
    Garrido Costa, Cristina
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (02): : 225 - 228
  • [45] Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease
    Block, G
    Port, FK
    SEMINARS IN DIALYSIS, 2003, 16 (02) : 140 - 147
  • [46] COVID-19 and cardiovascular disease in patients with chronic kidney disease
    Del Vecchio, Lucia
    Balafa, Olga
    Dounousi, Evangelia
    Ekart, Robert
    Fernandez, Beatriz Fernandez
    Mark, Patrick B.
    Sarafidis, Pantelis
    Valdivielso, Jose M.
    Ferro, Charles J.
    Mallamaci, Francesca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (02) : 177 - 189
  • [47] The contribution of thyroid dysfunction on cardiovascular disease in patients with chronic kidney disease
    Tatar, Erhan
    Kircelli, Fatih
    Ok, Ercan
    ATHEROSCLEROSIS, 2013, 227 (01) : 26 - 31
  • [48] Evidence for increased cardiovascular disease risk in patients with chronic kidney disease
    Coresh, J
    Astor, B
    Sarnak, MJ
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (01): : 73 - 81
  • [49] Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease
    Mills, Katherine T.
    Chen, Jing
    Yang, Wei
    Appel, Lawrence J.
    Kusek, John W.
    Alper, Arnold
    Delafontaine, Patrice
    Keane, Martin G.
    Mohler, Emile
    Ojo, Akinlolu
    Rahman, Mahboob
    Ricardo, Ana C.
    Soliman, Elsayed Z.
    Steigerwalt, Susan
    Townsend, Raymond
    He, Jiang
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (20): : 2200 - 2210
  • [50] DOES ALLOPURINOL IMPROVE CARDIOVASCULAR AND KIDNEY RISK IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?
    Mehedinti, Ana-Maria
    Popa, Otilia
    Lipan, Mariana
    Dumitru, Dana
    Mircescu, Gabriel
    Capusa, Cristina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1445 - 1445